Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pavia
Clinical trial register · Italy

Clinical Trials in Pavia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia117 Istituti Clinici Scientifici Maugeri SpA34 University of Pavia24 AstraZeneca23 Hoffmann-La Roche14
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Pavia

562 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Bari, Brescia, Catania, Florence, Genova, Modena, Parma, Pavia
2019-11-05
Active, closed
Niguarda Hospital
Phase 2
28
Alessandria, Bergamo, Bologna, Brescia, Milan, Novara, Pavia, Roma
2019-10-04
Active, closed
NeuroDerm Ltd.
Phase 3
381
Arcugnano, Cassino, Chieti, Grosseto, Milan, Naples, Pavia, Roma
2019-09-30
Active, closed
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma
DrugsIbrutinib·Rituximab
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
175
Ponderano, Milan, Torino, Ancona, Bari, Brescia, Cagliari, Pavia
2019-09-27
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Palermo, Foggia, Genova, Milan, Monza, Pavia, Roma
2019-09-23
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
200
Pavia
2019-09-13
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Aviano, Bergamo, Brindisi, Meldola, Milan, Novara, Parma, Pavia
2019-08-27
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Naples, Rome, Genoa, Milan, Pavia, Orbassano, Cefalù
2019-08-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Roma, Orbassano, Vicenza, Arezzo, Catania, Milan, Naples, Pavia
2019-07-24
Recruiting
National Institute of Allergy and Infectious Diseases (NIAID)
Observational
3,000
Pavia
2019-07-22
Active, closed
Amgen
Phase 3
457
Milan, Palermo, Pavia, Roma
2019-07-19
Recruiting
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
NCT04033224Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
1,000
Empoli, Lido di Camaiore, Rozzano, San Donato Milanese, Monza, Brindisi, Florence, Pavia
2019-07-16
Recruiting
CNAO National Center of Oncological Hadrontherapy
Observational
40
Pavia
2019-07-16
Active, closed
Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients
NCT03807414Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
270
Esine, Empoli, San Donato Milanese, Benevento, Florence, Naples, Pavia, Perugia
2019-06-28
Active, closed
Exelixis
Phase 3
855
Meldola, Faenza, Arezzo, Modena, Padova, Pavia, Perugia, Terni
2019-06-25
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Acquaviva delle Fonti, Arezzo, Brescia, Florence, Milan, Negrar, Pavia, Perugia
2019-06-24
Recruiting
Surgimab
Phase 3
300
Pavia
2019-06-17
Recruiting
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms
NCT05748028Parkinson Disease, Multiple System Atrophy
Istituti Clinici Scientifici Maugeri SpA
Observational
280
Telese Terme, Lumezzane, Castel Goffredo, Mistretta, Veruno, Montescano, Milan, Pavia
2019-06-15
Active, closed
Celgene
Phase 1/2
438
Bergamo, Bologna, Milan, Naples, Pavia
2019-05-20
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Milan, Pavia, Naples
2019-03-20
Recruiting
Abbott Medical Devices
Observational
2,000
Naples, Pavia
2019-03-13
Active, closed
Novartis Pharmaceuticals
Phase 2
22
Pavia, Roma, Torino, Naples
2019-03-13
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT03664609Parkinson Disease, Essential Tremor, Dystonia
Boston Scientific Corporation
Observational
5,000
Pavia
2019-03-12
Active, closed
AstraZeneca
Phase 3
724
Florence, Genova, Milan, Orbassano, Padova, Pavia, Roma, Rozzano
2019-03-06
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Bologna, Catanzaro, Milan, Pavia, Pisa, Reggio Calabria, Roma
2019-01-30
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,500
Pavia
2019-01-01
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Ranica, Milan, Bari, Catania, Catanzaro, Lecco, Modena, Pavia
2018-12-11
Recruiting
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT04621201Diagnosed or Relapsed/Refractory Sarcomas
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Observational
120
Torino, Bologna, Florence, Genova, Milan, Pavia, Roma, Trieste
2018-12-06
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Pavia
2018-11-10
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
150
Pavia
2018-11-10
Active, closed
AstraZeneca
Phase 3
895
Milan, Naples, Orbassano, Pavia
2018-10-31
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
90
Pavia
2018-10-03
Active, closed
AstraZeneca
Phase 3
1,246
Arezzo, Milan, Naples, Orbassano, Parma, Pavia, Roma, Terni
2018-09-27
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa
2018-07-17
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
200
Pavia
2018-07-14
Active, closed
Hoffmann-La Roche
Phase 3
927
Bari, Naples, Trieste, Rome, Genoa, Milan, Pavia, Pozzilli
2018-05-28
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Milan, Naples, Pavia, Verona
2018-04-27
Active, closed
Bellicum Pharmaceuticals
Phase 1
15
Pavia, Rome, Turin
2018-02-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Milan, Pavia, Roma, Torino
2017-12-29
Recruiting
In-hospital Stellate Ganglion Block for Arrhythmic Storm
NCT05720936Arrhythmic Storm, Electrical Storm, Ventricular Fibrillation, Ventricular Tachycardia
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
500
Alessandria, Bentivoglio, Bologna, Pavia, Voghera, Legnago, Ancona, Asti
2017-11-07
Active, closed
Takeda
Phase 1/2
59
Florence, Pavia, Roma, Torino
2017-09-06
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Meldola, Rozzano, Milan, Naples, Pavia, Roma
2017-09-05
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Bari, Bologna, Pavia, Roma, Siena
2017-08-23
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
DrugsSavolitinib·Sunitinib
AstraZeneca
Phase 3
60
Arezzo, Meldola, Milan, Modena, Orbassano, Pavia, Roma
2017-07-25
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Varese, Meldola, Milan, Pavia, Rimini, Torino
2017-06-26
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
204
Pavia
2017-06-06
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Milan, Padova, Pavia, Torino, Udine
2017-05-22
Active, closed
Acerta Pharma BV
Phase 3
635
Bologna, Milan, Palermo, Parma, Pavia, Reggio Emilia, Rozzano, Turin
2017-04-05
Recruiting
Italian Sarcoma Group
Not applicable
100
Milan, Bologna, Florence, Pavia, Pisa, Rome, Trento
2017-03-16
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Milan, Pavia
2017-02-08
Active, closed
Celgene
Phase 1/2
466
Meldola, Pavia, Reggio Emilia, Rome, Torino
2016-10-14
Active, closed
AstraZeneca
Phase 3
1,126
Arezzo, Meldola, Milan, Naples, Orbassano, Pavia, Roma, San Giovanni Rotondo
2015-11-02
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Busto Arsizio, Meldola, Milan, Pavia
2015-08-06
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
250
Pavia
2015-03-24
Recruiting
Arrhythmias Detection in a Real World Population
NCT02275637Appropriate and Inappropriate Shock Therapy With ICD, Arrhythmias Detection
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
10,000
Bergamo, Bologna, Catania, Florence, Milan, Naples, Padua, Pavia
2014-09
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
400
Pavia
2014-05-05
Recruiting
Jules Bordet Institute
Not applicable
1,000
Biella, Bolzano, Carpi, Genova, Legnago, Milan, Parma, Pavia
2014-04
Recruiting
Boston Scientific Corporation
Observational
1,500
Arcugnano, Ferrara, Mestre, Milan, Pavia, Rome, Udine
2014-03-04
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bologna, Florence, Genoa, Monza, Naples, Padova, Pavia, Pisa
2013-04
Active, closed
Italfarmaco
Phase 2
90
Bari, Bergamo, Florence, Milan, Pescara, Pavia, Reggio Calabria, Vicenza
2013-03
Recruiting
Boston Scientific Corporation
Observational
4,800
Pavia, Pisa
2012-11-19
Active, closed
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176Heart Failure, Congestive Heart Failure
Boston Scientific Corporation
Not applicable
118
Milan, Naples, Pavia
2011-09-21
Rows per page Showing 501–562 of 562
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/pavia?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 562 of those studies with a site in Pavia.

How many clinical trials are recruiting in Pavia?

339 of the 562 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 25 have not yet opened recruitment, 180 are active but closed to new participants, and 18 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.